Retour sur lavenir.net
   NYXOAH 2.330 € (-4,90 %)     CIE BOIS SAUVAGE 316.000 € (+0,96 %)     KBC 114.800 € (+1,95 %)     SOFINA 228.000 € (+1,88 %)     AB INBEV 71.840 € (-0,08 %)     TINC 11.940 € (-2,77 %)     COLRUYT 33.060 € (-1,20 %)     GIMV 49.900 € (+0,81 %)     SOLVAY 26.220 € (+0,85 %)     SIPEF 95.500 € (+0,32 %)     UCB 243.900 € (+0,79 %)     EVS BROADC.EQUIPM. 31.900 € (+2,41 %)     PROXIMUS 6.890 € (-0,14 %)     BREDERODE 102.400 € (+0,59 %)     MELEXIS 82.000 € (+0,68 %)     BANQUP GROUP 2.190 € (-10,61 %)     SHURGARD 23.800 € (-0,42 %)     KBC ANCORA 81.100 € (+2,40 %)     TUBIZE-FIN 210.800 € (+1,44 %)     KINEPOLIS GROUP 29.700 € (+1,37 %)     CAMPINE 238.000 € (+3,03 %)     CENERGY 25.460 € (+6,00 %)     ASCENCIO 50.400 € (+0,90 %)     UMICORE 25.960 € (-0,84 %)     ONWARD MEDICAL 2.910 € (+2,83 %)     HOME INVEST BE. 19.280 € (+1,80 %)     FAGRON 25.150 € (+0,60 %)     D'IETEREN GROUP 171.800 € (+2,57 %)     TITAN S.A. 48.020 € (+0,33 %)     ELIA GROUP 139.700 € (+1,53 %)     AEDIFICA 71.700 € (+0,21 %)     GBL 81.900 € (+1,11 %)     ARGENX SE 697.800 € (-0,46 %)     ACKERMANS V.HAAREN 279.600 € (+2,04 %)     BPOST 1.800 € (+1,81 %)     VAN DE VELDE 30.300 € (-1,30 %)     FLUXYS BELGIUM D 20.000 € (+0,76 %)     VGP 81.000 € (+0,87 %)     INCLUSIO SA/NV 17.200 € (+4,88 %)     TESSENDERLO 21.350 € (-0,23 %)     DEME GROUP 188.600 € (+0,86 %)     SYENSQO 66.800 € (+0,45 %)     RECTICEL 10.820 € (+0,93 %)     XIOR 27.550 € (+0,92 %)     AZELIS GROUP 10.250 € (-0,58 %)     CELYAD ONCOLOGY 0.288 € (-0,69 %)     CMB.TECH 14.500 € (-0,55 %)     AGEAS 68.300 € (+0,29 %)     QRF 11.500 € (-1,29 %)     MONTEA 68.100 € (+1,64 %)     WDP 22.260 € (+1,09 %)     ONTEX GROUP 2.670 € (+0,38 %)     CARE PROPERTY INV. 13.240 € (+0,46 %)     VIOHALCO 19.560 € (+2,62 %)     EXMAR 11.600 € (-0,43 %)     JENSEN-GROUP 77.000 € (+0,79 %)     BEKAERT 41.750 € (+0,72 %)     DECEUNINCK 2.095 € (+1,70 %)     HYBRID SOFTWARE GR 4.140 € (+0,49 %)     IBA 15.620 € (+1,56 %)  
   PLANISWARE 18.760 € (+0,75 %)     VIRIDIEN 114.100 € (-0,95 %)     MAUNA KEA TECH 0.180 € (+2,04 %)     CVC CAPITAL 13.330 € (+2,22 %)     ONE EXPERIENCE 0.339 € (+0,89 %)     ASML HOLDING 1 418.600 € (+0,68 %)     PROSUS 40.905 € (+4,72 %)     VOPAK 47.300 € (+1,72 %)     AIRBUS 174.400 € (+2,88 %)     CELLECTIS 3.240 € (+5,74 %)     COFACE 16.480 € (+0,24 %)     DANONE 61.680 € (-0,29 %)     AIR LIQUIDE 183.380 € (+1,66 %)     ASM INTERNATIONAL 906.400 € (+0,62 %)     BUREAU VERITAS 27.160 € (+0,97 %)     ING GROEP N.V. 27.085 € (+2,46 %)     CARREFOUR 17.180 € (+0,53 %)     BNP PARIBAS ACT.A 92.340 € (+2,68 %)     ADP 113.300 € (+3,75 %)     CROSSJECT 2.410 € (+7,11 %)     ATON 0.015 € (+2,82 %)     BRUNEL INTERNAT 7.590 € (-2,06 %)     GALP ENERGIA-NOM 18.810 € (-1,49 %)     LEGRAND 155.350 € (+1,80 %)     EUROFINS SCIENT. 62.860 € (+0,45 %)     AIR FRANCE -KLM 11.065 € (+7,90 %)     INPOST 15.360 € (+0,13 %)     L'OREAL 368.200 € (+1,81 %)     BOUYGUES 50.440 € (+2,25 %)     LVMH 478.750 € (+1,30 %)     ALFEN 18.400 € (+3,95 %)     ENGIE 27.360 € (+0,70 %)     REXEL 37.250 € (+1,53 %)     AEGON 7.572 € (+1,34 %)     SMCP 5.195 € (+2,77 %)     BE SEMICONDUCTOR 277.600 € (+1,46 %)     TOTALENERGIES 77.360 € (-1,64 %)     HERMES INTL 1 642.500 € (+2,34 %)     EUTELSAT COMMUNIC. 3.804 € (+0,21 %)     STELLANTIS NV 6.698 € (+2,87 %)     KALRAY 12.840 € (+16,09 %)     SAFRAN 301.600 € (+5,82 %)     SIGNIFY NV 20.640 € (+0,49 %)     THALES 231.500 € (+0,78 %)     UNIBAIL-RODAMCO-WE 98.880 € (+1,31 %)     DASSAULT SYSTEMES 20.540 € (+1,08 %)     SOCIETE GENERALE 71.490 € (+3,91 %)     STMICROELECTRONICS 57.020 € (-1,57 %)     KERING 247.350 € (+2,21 %)     RENAULT 28.960 € (+3,95 %)     FACEPHI 1.980 € (-5,71 %)     EUROAPI 1.496 € (-0,27 %)     CATANA GROUP 2.350 € (+2,62 %)     CATANA GROUP 2.350 € (+2,62 %)     ADYEN 983.400 € (+2,66 %)     PHARMING GROUP 1.189 € (+6,35 %)     HAFFNER ENERGY 0.232 € (+30,48 %)     ALSTOM 17.060 € (+1,10 %)     EXOSENS 64.700 € (+0,15 %)     IPSOS 37.400 € (+1,74 %)  
News Réglementées
13/05/2026 09:00

Original-Research: INDUS Holding AG (von NuWays AG): BUY

Original-Research: INDUS Holding AG - from NuWays AG

13.05.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.


Classification of NuWays AG to INDUS Holding AG

Company Name:INDUS Holding AG
ISIN:DE0006200108
 
Reason for the research:Update
Recommendation:BUY
Target price:EUR 37
Target price on sight of:12 months
Last rating change:
Analyst:Sarah Hellemann

INDUS kicks off FY26 with a strong Q1 and raised guidance

Yesterday, INDUS released its Q1 report, following the release of preliminary revenue and adj. EBITA on April 30th. Key details from this strong Q1-release:

Kicking off the year with a strong Q1 performance, Q1 revenue grew by 9.4% yoy to € 442m, driven by improvements across segments. Inorganic growth contributed 2.2% yoy. The adj. EBITA rose by 70.7% yoy to € 42.5m, with the adj. EBITA margin increasing by 3.4pp yoy. Due to BETEK's successful management of the price increase in tungsten carbide as a key raw material, Material Solutions showed significantly elevated margins.

Material Solutions adj. EBITA margin came in hiked by 7.9pp yoy to 16.8% (eNuW: 14.7%) through positive pricing and volume developments in BETEK (51% of Material Solutions revenue in FY25). This clearly underlines once again BETEK's proactive and dynamic management of the special situation concerning tungsten. Not only has it established sufficient supply, despite significant elevation of cost. Backed by the holding, it is seizing the opportunity to gain market share in tungsten-related products, as smaller competitors partially signal silent retreat. Segment revenue rose by 17.5% to € 168m (eNuw: € 174m) and adj. EBITA soared by 122% yoy to € 28.2m (eNuW: € 24.7m).

Engineering beat growth expectations with revenue of € 131m (eNuW: € 124m), up 6.1% yoy, based on stronger than anticipated organic growth of 2.3% yoy. Inorganic growth contributed + 3.8% yoy. The adj. EBITA margin reached only 3.9% (eNuW: 5.5%), impacted by seasonality and capacity utilization, leading to an adj. EBITA of € 5.1m (eNuW: € 6.8m), down 20.3% yoy.

Infrastructure beat bottom-line expectations. The adj. EBITA rose by 36% yoy to € 13.6m, due to cost optimization, efficiency gains and the successful repositioning of a portfolio company. Revenue grew by 6.1% yoy to € 143m (eNuW: € 144m) largely in line with expectations and supported by inorganic growth of 5.1% yoy from FY25 acquisitions.

The order backlog rose by 24.5% yoy to € 826m, supported by strong order intake, up 15.4% yoy to € 525m (book-to-bill ratio 1.19). This was mainly driven by growth in tungsten carbide-tipped wear tools supporting a 28.3% yoy increase in Material Solutions orders and strong demand for digital infrastructure products leading to a 25.5% yoy increase in Infrastructure orders. Engineering orders came in slightly lower by 3.8% yoy at € 165m, while maintaining a strong book-to-bill for the segment at 1.26x.

Working Capital increased by € 57.8m yoy, reflecting investments in inventory of c. € 68.5m yoy. C. € 48m (eNuW) of this should be related to higher tungsten-related material prices and risen tungsten purchase volume. Under current circumstances, we view increased procurement of tungsten at higher prices as essential to raising BETEK's market share against small competitors. While the pricing volatility could also pose risks of normalization, we view the demand for tungsten to remain high in the months to come. This investment into inventory has a strong negative impact on the Free Cash Flow, reported at € -74.1m, it is seen as an investment into stronger organic growth in BETEK for the short- to mid-term.

Starting strong into the year on a positive signal, the increased FY26 guidance reflects the expectation of solid underlying developments and a short-term catalyst from the tungsten special situation. FY26e revenue is anticipated at € 1.92 bn (eNuW), implying growth of 10.7% (eNuW). Adj. EBITA is seen to rise by 21.1% yoy to € 179m (eNuW), supported by a stronger topline, disciplined cost management, operational excellence improvements and inorganic first-time contributions. Over the course of the year, we expect the topline to strengthen, driven by positive price and volume effects from organic growth, seasonality and first-time revenue contributions from acquisitions announced so far. Confirming BUY at a PT of € 37.0, based on FCFY 26e.

You can download the research here: indus-holding-ag-2026-05-13-update-en-a74d9
For additional information visit our website: https://www.nuways-ag.com/research

Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben analysierten Unternehmen befindet sich in der vollständigen Analyse.
++++++++++


The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2326660  13.05.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière